Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Viewpoint Catheter, further addressing market need to reduce physician exposure to harmful x-ray radiation during image-guided, endovascular procedures

Centerline Biomedical receives FDA 510(k) clearance for new IOPS® Viewpoint Catheter, further addressing market need to reduce physician exposure to harmful x-ray radiation during image-guided, endovascular procedures

Cleveland, October 4, 2022 – Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer.  Mr. Khan has more than two decades of executive...
Centerline Biomedical joins ORSIF

Centerline Biomedical joins ORSIF

Cleveland, October 4, 2022 – Centerline Biomedical, Inc. (“Centerline”), which recently commercialized its Intra-Operative Positioning Systems IOPS®, has appointed Gulam Khan, Chief Executive Officer.  Mr. Khan has more than two decades of executive...